Skip to content

Clinical trials

Hypogonadism trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypogonadism Country / region: United Kingdom Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20082
20101
20133
20151
20163
20181
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Not yet recruiting2
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Barnsley Hospital2
Bayer2
Eli Lilly and Company2
Acerus Biopharma Inc.1
Imperial College London1
Mereo BioPharma1
Neurocrine UK Limited1
Sheffield Teaching Hospitals NHS Foundation Trust1
Takeda1
Tameside Hospital NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypogonadism17
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Turner Syndrome2
Addison Disease1
Adrenal Hyperplasia, Congenital1
Androgen-Insensitivity Syndrome1
Dwarfism, Pituitary1
Eunuchism1
Hyperprolactinemia1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.